You are here
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Closed on 8 April 2009
Second discussion paper: Improving access to Consumer Medicines Information (CMI) and Product Information (PI)
Closed on 30 March 2007
Closed on 16 December 2005